Drug Discovery Chemistry is a dynamic conference for medicinal, biophysical, and computational chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule and macrocyclic drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's interests by going back and forth among concurrent tracks.
Speakers from industry are always strongly represented at this event. In 2025, participating organizations included AbbVie, AstraZeneca, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda Pharmaceuticals, as well as numerous emerging biotech firms.
Drug Discovery Chemistry will return to San Diego from April 13-16, 2026. In the meantime, we invite you to join us at Drug Discovery Chemistry Europe, taking place in Barcelona, Spain, 11-13 November 2025.